H EALTH R ELATED Q UALITY OF L IFE Fowad Khurshid PHCL 431 1.

Slides:



Advertisements
Similar presentations
Measuring outcomes Emma Frew October Measuring outcomes Learning objectives By the end of the session students should be able to – Explain how different.
Advertisements

Standardized Scales.
ASSESSING RESPONSIVENESS OF HEALTH MEASUREMENTS. Link validity & reliability testing to purpose of the measure Some examples: In a diagnostic instrument,
Psychological Assessment
Psychiatric evaluation of patients with dual upset Professor Iqbal Singh.
Disability Statistics at NCHS: An Update
The Definition and Measurement of Disability
Cross-Cultural Use of Measurements: Development of the Chinese SF-36 Health Survey Xinhua S. Ren, Ph.D. Boston University School of Public Health, Boston,
Measuring Disability in a Survey or Census Context: Parallel Work Advancing the Field Barbara M. Altman, Ph.D. Disability Statistics Consultant.
Does Health Promotion Work? Puja Myles. Outline of lecture Learning Outcomes Designing a health promotion intervention Types of evaluation questions and.
Transcultural Research Prof. N.J.Mathers Institute of primary and community care University of Sheffield.UK 06/Nov/2007.
Quality of Life in Oporto and South of Douro Region – Comparison of EQ-5D and SF-36 Introdução à Medicina Turma 6 – 2006/2007.
Quality of life Assessment introduction
QUALITY OF LIFE ASSESSMENT IN PEOPLE LIVING WITH HIV/AIDS Antonieta Medina Lara HIV/AIDS and STI Knowledge Programme Liverpool School of Tropical Medicine.
Self-Report Measures of Functional Status and Quality of Life: Adults Sandra A. Mitchell, CRNP, M.Sc.N., AOCN National Institutes of Health Bethesda, MD.
Quality of Life Assessment in Clinical Trials Adapted from Introduction to Clinical Trials Biostatistics.
Jennifer Madans Associate Director for Science
Measuring the benefit of palliative chemotherapy in women with platinum refractory/ resistant ovarian cancer Michael Friedlander Phyllis Butow, Martin.
MAPPING THE DIABETES HEALTH PROFILE (DHP-18) ONTO THE EQ-5D AND SF-6D GENERIC PREFERENCE BASED MEASURES OF HEALTH Brendan Mulhern 1, Keith Meadows 2, Donna.
National Outcomes and Casemix Collection Training Workshop
Keele Assessment of Participation (KAP): A new instrument for measuring participation restriction in population surveys Ross Wilkie, George Peat, Elaine.
1 The valuation of disease-specific questionnaires for QALY analysis  To rescue data in absence of an utility measure  Growth hormone deficiency in adults.
Some Approaches to Evaluation: A Focus on Outcomes Assoc Prof Jan Sansoni Australian Health Outcomes Collaboration Australian Health Services Research.
Translation and Cross-Cultural Equivalence of Health Measures.
September 19-20, 2005 Rio de Janeiro, Brazil Internationally Comparable General Disability Measures Barbara M. Altman National Center for Health Statistics.
Measuring quality processes and outcomes Rod O'Connor PhD Rod O'Connor & Associates P/L Adjunct Senior.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 11: Cost-utility analysis – Part 4.
Advising on Test Validity: Comments on Denny Borsboom Neil K. Aaronson The Netherlands Cancer Institute KNAW Colloquium on Advising on Research Methods.
Standardization and Test Development Nisrin Alqatarneh MSc. Occupational therapy.
GENERAL INTRODUCTION TO HEALTH MEASUREMENT (Note: I have added explanatory notes to many of the slides; to see these you will need to save the file and.
FDA Approach to Review of Outcome Measures for Drug Approval and Labeling: Content Validity Initiative on Methods, Measurement, and Pain Assessment in.
University of Minnesota Medical Technology Evaluation and Market Research Department of Healthcare Management Course: MILI/PUBH 6589 Spring Semester, 2013.
PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Joseph Finkelstein, MD, PhD, MA, CCRP ICTR Clinical Registry Workshop, 10 November 2010.
Introduction Patients with tumors affecting the spine have significant impairments in Quality of Life domains that include physical function, neural function,
1 The Patient Perspective: Satisfaction Survey Presented at: Disease Management Colloquium June 22, 2005 Shulamit Bernard, RN, PhD.
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
Workshop The science and methodologies behind HTA, diversity and commonality across the EU Achieving more patient centred HTA in different countries.
This Outcome Report is based on data from patients who completed a Functional Restoration Programme (FRP) at the RealHealth Treatment Centre in Coventry.
Lecture 6: Reliability and validity of scales (cont) 1. In relation to scales, define the following terms: - Content validity - Criterion validity (concurrent.
1 Chapter 24 Scale Development and Statistical Analysis Methods for Scale Data.
Al wakeel J, Bayoumi M, Al Ghonaim M, Al Harbi A, Al Swaida A, Mashraqy A.
Competency in Older Adults: Clinical and Legal Perspectives The Role of Cognitive and Neuropsychological Evaluations John Crumlin, PhD Assistant Director,
1 Task Force on the Development of a Common Instrument to Measure Health States: Identification of Domains Sarah Connor Gorber; Cameron N. McIntosh; Julie.
Interviewers training, ScoPeO evaluation(Country), (date) Module 2: Presenting the main concepts addressed in the ScoPeO questionnaire.
Development of Physical and Mental Health Summary Scores from PROMIS Global Items Ron D. Hays ( ) UCLA Department of Medicine
1 National Outcomes and Casemix Collection Training Workshop Adult Ambulatory.
Evidence and Information for Policy Health as a multi-dimensional construct and cross-population comparability Colin Mathers (WHO) on behalf of Taskforce.
1 Interactive introduction in Quality of life Assessment Jan J. v. Busschbach, Ph.D. Department of Medical Psychology and Psychotherapy, Erasmus MC
OLGA: A nice niche designed to meet your evolving needs Pennifer Erickson, Ph.D. Presented at the Spring meeting of the Special Library Association’s Pharmaceutical.
VALIDITY AND VALIDATION: AN INTRODUCTION Note: I have included explanatory notes for each slide. To access these, you will probably have to save the file.
SPECA Meeting, Paris, June 16, 2006 Activities Related to Health and Disability Statistics in the UNECE Region and Globally Jennifer H. Madans for the.
Hermann P. G. Schneider, Alastair H. MacLennan and David Feeny
EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with RA, Non-Inflammatory Disorders (NIRD), and Fibromyalgia (FM)
Translation and Cross-Cultural Equivalence of Health Measures
Quality of Life (QOL) & Patient Reported Outcomes (PRO) Lori Minasian, MD Chief, Community Oncology and Prevention Trials Research Group, DCP, NCI, NIH,
Principles of Assessment and Outcome Measurement for Physical Therapists ksu. edu. sa Dr. taher _ yahoo. com Mohammed TA, Omar,
Long-Term Outcomes after Acute Stroke Treatment Larry B. Goldstein, M.D. Professor of Medicine (Neurology) Center for Cerebrovascular Disease Center for.
PT 142 – Assessment in Physical Therapy Prepared by: Almira A. Tagala-Manuel, PTRP Prepared by ATM for PT 142 students AY
Copyright 2005 Lippincott Williams & Wilkins Chapter 4 Prevention and the Promotion of Health, Wellness, and Fitness The function of protecting and developing.
CoRPS Nice Center of Research on Psychology in Somatic diseases Quality of life and symptom assessment in long-term blood cancer survivors (chapter.
CoRPS London 26 & 27 October 2010 Center of Research on Psychology in Somatic diseases Understanding PRO in hematological disorders: Do we have a consensus?
Instrument Development and Psychometric Evaluation: Scientific Standards May 2012 Dynamic Tools to Measure Health Outcomes from the Patient Perspective.
Health Related Quality of Life after serious occupational injuries and long term disability Presenter: Ibishi Nazmie MD,PhD University Clinical Center.
Table 1. Characteristics of generic HRQOL assessments in adult physical activity research Peter D. Hart et al. Systematic Review of Health-Related Quality.
The burden of disease in patients with personality disorder indicated for psychotherapy: Arguments for necessity of care Djøra Soeteman, MSc
Quality of Life Assessment
Patient Baseline Assessment
Understanding Results
Expert Group on Quality of Life Indicators
Measuring outcomes Emma Frew October 2012.
Presentation transcript:

H EALTH R ELATED Q UALITY OF L IFE Fowad Khurshid PHCL 431 1

Q UALITY OF L IFE “Quality of life” concept emerged in US after World War II Attempted to describe the effect of the acquisition of material goods on people’s lives Concept of health also reassessed after World War II by WHO Rather than being defined as the absence of disease, it incorporated the perception of complete physical, mental, and social well-being 2

F ACTORS A FFECTING Q UALITY OF L IFE 3

D EFINITIONS OF Q UALITY OF L IFE Quality of life is the degree of need and satisfaction within the physical, psychological, social, activity, material and structural area (Hörnquist, 1982). Quality of life is the subjective evaluation of good and satisfactory character of life as a whole (De Haes, 1988). Health related quality of life is the subjective experiences or preferences expressed by an individual, or members of a particular group of persons, in relation to specified aspects of health status that are meaningful, in definable ways, for that individual or group (Till, 1992). Quality of life is a state of well-being which is a composite of two components: 1) the ability to perform everyday activities which reflects physical psychological, and social well-being and 2) patient satisfaction with levels of functioning and the control of disease and/or treatment related symptoms (Gotay et al., 1992). An individual’s perception of their position in life in the context of the culture and values systems in which they live and in relation to their goals, expectations, standards and concerns (WHO Quality of life Groups, 1993). 4

N O CLEAR DEFINITION BECAUSE Many possible definitions Multi-dimensionally Subjective Related to society 5

N O CLEAR DEFINITION BECAUSE Different origins of research: Clinical decision making : Does the patient benefit from the treatment? Epidemiology (public health): what is the morbidity of the population? Health economics : Is it worth the money? 6

Q UALITY OF L IFE 7 Core Domains Psychological Social Occupational Physical Typical items Depression/Anxiety/ Adjustment to illness Personal relationships, sexual interest, social & leisure activities Employment, cope household Pain/mobility/sleep/sexual functioning

H OW TO MEASURE QUALITY OF LIFE FORM A CLINICAL POINT OF VIEW ? Choose items Are you able to walk one kilometer ? Do you feel depressed ? Choose response mode Binary yes / no Multiple (Likert) yes / at bid / hardly / no Continuous ( Visual Analogue Scale ) Always ———— X — — Never Combine items to dimensions of quality of life Sum up the items belonging to one dimension Rescale sum on a scale from 0 to 100 8

H EALTH - RELATED QUALITY OF LIFE (HRQL) Assessment includes the effect of health on well- being using environmental and economic features of the study population Outcome measures may include patient-reported levels of pain, emotional and psychological status as well as levels of functioning 9

H EALTH - RELATED QUALITY OF LIFE (HRQL) HRQL is a concept that reflects an individual’s perception of how an illness and its treatment affect life. HRQL instruments are necessary to quantify the burden of a disease and functional impairment in survivors Generic or disease specific 10

ATTRIBUTES OF HRQ O L Disease, disorder Impairment Disability Handicap 11

E XAMPLES OF IMPAIRMENTS, DISABILITIES AND HANDICAPS 12 Impairments Pain Fatigue Anxiety Depression Incontinence Disabilities Bathing Dressing Climbing stairs Ability to work Partnership problems Handicaps Physical independence Mobility Social integration Orientation Economic self- sufficiency

I NSTRUMENTS FOR A SSESSING Q O L Generic instruments These instruments can be used with any population. They generally cover perceptions on overall health and also questions on social, emotional and physical functioning, pain and self-care. Can be universally applied With limitations, allow comparisons of different diseases or populations Do not allow disease-specific aspects to be studied Specific instruments This type of instrument evaluates a series of health dimensions specific to a disease. Specific disease instruments are more comprehensive 13

GENERIC VERSUS DISEASE- SPECIFIC INSTRUMENTS TypeAdvantagesDisadvantages Generic or general Broadly applicableMay not be responsive to changes in health Summarizes range of concepts May not be relevant for specific populations May detect unanticipated effects Results may be difficult to interpret Disease specific More relevant for specific populations Cannot compare across populations More responsive to changes in health Cannot detect unanticipated effects 14

EXAMPLES OF GENERAL HRQOL MEASURES General Health Status Instruments 15 Medical Outcome Study Short-Form Health Surveys (MOS- SF)4,5,6,7 (includes SF-12, SF-36, and SF-36 Version 2) EuroQol-5D (EQ-5D)11 Quality of Well-Being (QWB) Scale12 Sickness Impact Profile (SIP)14 Dartmouth COOP15

EXAMPLES OF DISEASE-SPECIFIC HRQOL MEASURES Hypertension  Health Status Index (HSI)16  The Subjective Symptom Assessment Profile17 Benign Prostatic Hyperplasia  American Urological Association Symptom Index (AUASI)18  BPH Impact Index19 Asthma and Allergy  Living with Asthma Questionnaire20  Life Activities Questionnaire for Adult Asthma21 Diabetes Mellitus  Diabetes-Specific QoL Instrument (DQOL)22 16

G ENERIC I NSTRUMENTS FOR A SSESSING Q O L QoL QuestionnairesAdministered by Short-Form 36 (SF-36)Self Sickness Impact ProfileObserver Beck Depression InventoryObserver Hamilton Depression Rating Scale Observer Center for Epidemiological Studies of Depression Observer Hamilton Anxiety ScaleObserver Fatigue Severity ScaleSelf 17

SF-36 Brief, comprehensive self report questionnaire - 36 items - 8 subscales (health concepts) 8 dimensions of health Physical functioning (10 items) Role limitation due to physical problems (4 items) Pain (2 items) General health perception (6 items) Energy / vitality (4 items) Social functioning (2 items) Role limitation due to emotional problems (3 items) Mental health (5 items) 18

A PPROACHES TO CROSS - CULTURAL INSTRUMENT DEVELOPMENT Sequential approach (transfering an existing questionnaire to another culture, e.g. SF-36 Health Survey) Parallel approach (assembling an instrument based on existing scales from different cultures, e.g. EORTC QLQC30) Simultaneous approach (cooperative cross-cultural development of a questionnaire, e.g. WHO-QOL) 19

S TEPS IN INSTRUMENT DEVELOPMENT Item development (focus groups; expert pannel; cognitive debriefing)... Translation (foreward, backward, piloting) Psychometric testing (reliability, validity, responsiveness) Norming (representative population sample, weighing ) 20

A SSESSMENT OF Q O L INSTRUMENTS (I) Validity: ability to distinguish QoL of patients with different levels of health status Interpretability: measurement expresses small, moderate, serious change or improvement in QoL 21

A SSESSMENT OF Q O L INSTRUMENTS (II) Reliability / reproducibility: same results for repeated measurement Sensitivity / Responsiveness: ability to detect small but clinically significant changes in QoL 22

V ALIDATION PHASES 23 Outlook (qualitative) face validity – language – outlook, letter size – simplicity content validity Content (quantitative) criteria validity construct validity – convergence – divergence reliability – internal consistency – reproducibility

L OCAL ADAPTATION OF Q O L INSTRUMENTS Validity of different language versions has to be equal with the validity of the original version Mirror translation is not recommended 24

H OW A RE Q O L M EASURES U SED IN THE H EALTHCARE S ETTING ? Useful to incorporate into: Cost-effective analyses Health policy people use QoL to add the “human” impact into cost- effective analyses Clinical Trials How do interventions and outcomes alter QoL? Everyday clinical practice QoL potentially a major factor for both doctor and patient considering whether to try specific therapies (ie chemotherapy in advanced cancers) Epidemiological studies 25

Q UALITY OF LIFE ASSESSMENT CAN :- Provide data to assist patient and doctor with decision making about treatments Help evaluate outcome of different treatments in outcome trials Identify patients who might benefit from supportive interventions To be used to inform policy and resource allocation Reveal benefits to patients despite objective toxicity be of prognostic value in determining which patient is most likely to benefit from treatment 26

U SE OF QOL Indicator of psychological distress Aide referral Prognostic value - predictive of treatment outcomes Decision making tool 27

C HOOSING A TEST TO MEASURE QUALITY OF LIFE Generic or specific test Index or profile Single instrument or battery? Is it suitable for target population Is it psychometrically sound? Which response format is used? What is the time frame? Method of administration Who will complete assessment? 28

M ETHODS OF ADMINISTRATION Face to face interview by trained interviewers telephone interviews self-report questionnaires pencil and paper computer - touch screens and so on 29

W HY DOCTORS DO NOT MEASURE Q UALITY OF L IFE They feel that clinical judgement is sufficient Do not know which tests to use Feel it takes too much time Think that the patient will get upset Do not know how to analyse tests Do not know how to interpret data 30

T HANK YOU 31